日韩小电影网址,九九九九黄色,国产又黄又嫩又爽又猛,AV久九张娅,久久久久不卡免费,亚洲色综合区,欧洲mv一区二区,亚洲第一区在线,日少妇视频

Quarkmed Dynamics

Quarkmed will keep moving forward, paying attention to hot topics in the industry, discussing the latest developments in the industry, and working with enterprises to promote new progress in medicine.

Partial Cooperative ClientsQuarkmed NewsTeam Style

Home>Quarkmed Dynamics

302025-09

Quarkmed is invited to attend the Hangzhou Biomedicine Industry-Finance Summit

On April 29th, the "Hangzhou Biomedicine Industry-Finance Summit," hosted by Tailong Investment and co-supported by Hangzhou Industrial Investment Group, High-tech Financial Investment Group, and Tig...

302025-09

Exploring Innovative Paths in Radiopharmaceuticals: Quarkmed Joins Forces with Industry Chain to Bui

2025 Future XDC New Drug ConferenceFrom April 17th to 18th, 2025, the "Future XDC New Drug Conference" was successfully held in Chengdu. At this interdisciplinary gathering, radiopharmaceuticals, as a...

302025-09

Great news! Quarkmed and Heyue Pharma have proudly made it to the TOP 10 list of clinical trial

In the wave of medical research and innovation, every collaboration signifies further exploration into unknown territories. Recently, Quarkmed and its subsidiary Heyue Medicine have ranked among the t...

302025-09

The VIQU Nuclear Medicine CXO Alliance Launch Ceremony and "Comprehensive Exploration: In-depth Anal

On the afternoon of November 28, 2024, with the countdown on the large screen starting, the VIQU Nuclear Medicine CXO Alliance set sail brilliantly in Shanghai, marking a successful opening ceremony. ...

302025-09

Quarkmed Completes Series A Financing, Pioneering a New Pattern in Multi-field Clinical Services!

Recently, Quarkmed successfully completed its Series A financing, securing tens of millions of RMB in funding led by Tai Kun Fund, with follow-on investments from Mint Angel Fund and Guoshun Jianheng ...

182023-07

A meeting for phase III clinical trial researchers for 18F-NaF injection was held successfully

On September 30, 2020, a meeting for phase III clinical trial researchers for 18F-NaF injection was held successfully. The meeting is organized by Quarkmed and presided over by Huo Li, director of Nu...

182023-07

CRO Service for NICS to Assist IVF Technology Development

Recently, the clinical trial of Non-invasive Capacity Screening (NICS) developed by Yikon Genomics, an enterprise dedicated to the development and application of single-cell whole-genome amplification...

182023-07

Commendatory Letter from Our Client with 4 “Extraordinarily”

Recently we have received a commendatory letter from our client, Sichuan Pharmaceutical, Inc, giving us a highly praise and recognition for our staff’s excellent service competence.Sichuan Pharm...

1 2

Contact Us

010-86469979

Address：Ping An Fortune Center, Lize Financial Business District of Beijing

Follow the Wechat official account

? 夸克醫(yī)藥版權(quán)所有京ICP備2024074643號-1

Tel
010-86469979
Scan
Follow the Wechat official account
Inquiry
掃碼添加客服

彭阳县| 泾阳县| 临泉县| 桐乡市| 绵阳市| 西畴县| 潜山县| 铅山县| 台江县| 永清县| 万全县| 惠水县| 宜君县| 满洲里市| 鄂尔多斯市| 湘西| 大兴区| 定陶县| 新泰市| 南乐县| 永春县| 信阳市| 肇东市| 浮梁县| 社会| 广昌县| 霸州市| 武冈市| 太仓市| 调兵山市| 泰州市| 台南县| 东台市| 廉江市| 陕西省| 洪泽县| 虹口区| 淮安市| 深州市| 宜兰县| 吴忠市|

日韩小电影网址,九九九九黄色,国产又黄又嫩又爽又猛,AV久九张娅,久久久久不卡免费,亚洲色综合区,欧洲mv一区二区,亚洲第一区在线,日少妇视频

About

Service

Advantage

Quarkmed Dynamics

Featured Services

Human Resources

Mail System

CTMS System

Quarkmed Dynamics

Quarkmed is invited to attend the Hangzhou Biomedicine Industry-Finance Summit

Exploring Innovative Paths in Radiopharmaceuticals: Quarkmed Joins Forces with Industry Chain to Bui

Great news! Quarkmed and Heyue Pharma have proudly made it to the TOP 10 list of clinical trial

The VIQU Nuclear Medicine CXO Alliance Launch Ceremony and "Comprehensive Exploration: In-depth Anal

Quarkmed Completes Series A Financing, Pioneering a New Pattern in Multi-field Clinical Services!

A meeting for phase III clinical trial researchers for 18F-NaF injection was held successfully

CRO Service for NICS to Assist IVF Technology Development

Commendatory Letter from Our Client with 4 “Extraordinarily”

Contact Us

010-86469979

Follow the Wechat official account

Follow the Wechat official account

掃碼添加客服